Product
Insulin glargine + Lixisenatide
Aliases
Insulin glargine/Lixisenatide
1 clinical trial
1 indication
Indication
Type 2 Diabetes MellitusClinical trial
A Randomized, 24 Weeks, Active-controlled, Open-label, 2-arm Multicenter Study Comparing the Efficacy and Safety of iGlarLixi to IDegAsp in Chinese Type 2 Diabetes Mellitus Participants Insufficiently Controlled With Oral Antidiabetic Drug(s)Status: Completed, Estimated PCD: 2023-10-20